DE69603681T2 - Verwendung mindestens eines beta-adrenergen Agonisten als Antagonist der Substanz P - Google Patents

Verwendung mindestens eines beta-adrenergen Agonisten als Antagonist der Substanz P

Info

Publication number
DE69603681T2
DE69603681T2 DE69603681T DE69603681T DE69603681T2 DE 69603681 T2 DE69603681 T2 DE 69603681T2 DE 69603681 T DE69603681 T DE 69603681T DE 69603681 T DE69603681 T DE 69603681T DE 69603681 T2 DE69603681 T2 DE 69603681T2
Authority
DE
Germany
Prior art keywords
antagonist
beta
substance
adrenergic agonist
adrenergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69603681T
Other languages
English (en)
Other versions
DE69603681D1 (de
Inventor
Lionel Breton
Lacharriere Olivier De
Jacques Leclaire
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Publication of DE69603681D1 publication Critical patent/DE69603681D1/de
Application granted granted Critical
Publication of DE69603681T2 publication Critical patent/DE69603681T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DE69603681T 1995-10-23 1996-10-01 Verwendung mindestens eines beta-adrenergen Agonisten als Antagonist der Substanz P Expired - Fee Related DE69603681T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9512447A FR2740040B1 (fr) 1995-10-23 1995-10-23 Utilisation d'au moins un agoniste beta-adrenergique en tant qu'antagoniste de substance p

Publications (2)

Publication Number Publication Date
DE69603681D1 DE69603681D1 (de) 1999-09-16
DE69603681T2 true DE69603681T2 (de) 1999-11-25

Family

ID=9483809

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69603681T Expired - Fee Related DE69603681T2 (de) 1995-10-23 1996-10-01 Verwendung mindestens eines beta-adrenergen Agonisten als Antagonist der Substanz P

Country Status (14)

Country Link
US (2) US5958432A (de)
EP (1) EP0769293B1 (de)
JP (1) JP3636473B2 (de)
AR (1) AR004052A1 (de)
BR (1) BR9611302A (de)
CA (1) CA2222311C (de)
DE (1) DE69603681T2 (de)
DK (1) DK0769293T3 (de)
FR (1) FR2740040B1 (de)
HU (1) HUP9900511A3 (de)
NO (1) NO312273B1 (de)
PL (1) PL186366B1 (de)
RU (1) RU2169552C2 (de)
WO (1) WO1997015281A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948972A (en) * 1994-12-22 1999-09-07 Kla-Tencor Corporation Dual stage instrument for scanning a specimen
AU2001282988B2 (en) * 2000-07-26 2006-01-05 Atopic Pty Ltd Methods for treating atopic disorders
ITPD20010187A1 (it) * 2001-07-23 2003-01-23 Cutech Srl Trattamento del follicolo polifero, in particolare contro la caduta dei capelli
EP1295599A1 (de) * 2001-09-21 2003-03-26 Boehringer Ingelheim International GmbH Verfahren zur Behandlung oder Verhütung von atopischer Dermatitis
US20030219573A1 (en) * 2002-03-27 2003-11-27 Torgny Falk Absorbent product
US8343519B2 (en) * 2003-02-19 2013-01-01 L'oreal S.A. Chemical enhancer and method
EP1613266A4 (de) * 2003-04-15 2009-05-06 Theraquest Biosciences Llc Verfahren zur behandlung von schmerzen und zusammensetzungen zur verwendung dafür
WO2006054513A1 (ja) * 2004-11-19 2006-05-26 Kissei Pharmaceutical Co., Ltd. 神経因性疼痛の予防又は治療剤
DE602006015387D1 (de) 2005-04-13 2010-08-26 Astion Dev As Beta-2 Adrenoceptor Agonisten zur Behandlung von Bindegewebserkrankungen der Haut
JP2011509981A (ja) * 2008-01-18 2011-03-31 サントル ナショナル ドゥ ラ ルシェルシュ スィヤンティフィック（セーエヌエルエス） 神経障害性疼痛の治療に使用される化合物
GB0805535D0 (en) * 2008-03-27 2008-04-30 Univ Leicester Scar prevention
US8420114B2 (en) * 2008-04-18 2013-04-16 Warsaw Orthopedic, Inc. Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation
BRPI1008008A2 (pt) * 2009-02-24 2016-02-23 Novartis Ag usos de antagonistas do receptor de nk
GB2513297A (en) 2013-03-08 2014-10-29 Univ Leicester Methods
US9937117B2 (en) 2015-07-09 2018-04-10 Galderma S.A. Method of reducing hair loss associated with chemotherapy
WO2019230230A1 (ja) * 2018-05-29 2019-12-05 株式会社ナノエッグ アトピー性皮膚炎を治療または予防するための組成物
JP2022534826A (ja) * 2018-09-08 2022-08-04 タン ウェン 炎症性腸疾患及びその腸管外発現の処置のためのアドレナリン作動性β２受容体アゴニストのＲ－エナンチオマーの新たな使用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1474316A (en) * 1975-02-12 1977-05-25 Seperic O-aminoalkyl oximes
US4038417A (en) * 1975-06-19 1977-07-26 Nelson Research & Development Company Method for treatment of psoriasis
US4525359A (en) * 1982-12-10 1985-06-25 Greenway Frank L Iii Treatment for selective weight control
US5366731A (en) * 1990-08-24 1994-11-22 Wisconsin Alumni Research Foundation Cosmetic compositions containing secosterol compounds
IL99368A (en) * 1991-09-02 1996-01-19 Teva Pharma Preparations for the treatment of psoriasis and atopic dermatitis, which contain the result of xanthine
CA2114968A1 (en) * 1993-02-25 1994-08-26 John Wille Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity
JPH07258067A (ja) * 1994-03-18 1995-10-09 Kao Corp 浴用剤組成物
FR2719474B1 (fr) * 1994-05-05 1996-05-31 Oreal Utilisation d'un antagoniste de substance P dans une composition cosmétique et composition obtenue.

Also Published As

Publication number Publication date
NO976143D0 (no) 1997-12-30
PL324924A1 (en) 1998-06-22
EP0769293B1 (de) 1999-08-11
WO1997015281A1 (fr) 1997-05-01
AR004052A1 (es) 1998-09-30
BR9611302A (pt) 1999-03-30
NO312273B1 (no) 2002-04-22
US5958432A (en) 1999-09-28
MX9710475A (es) 1998-08-30
CA2222311C (fr) 2006-11-28
FR2740040A1 (fr) 1997-04-25
US6267972B1 (en) 2001-07-31
DK0769293T3 (da) 1999-12-06
EP0769293A2 (de) 1997-04-23
FR2740040B1 (fr) 1997-12-05
HUP9900511A3 (en) 2000-09-28
NO976143L (no) 1998-06-03
RU2169552C2 (ru) 2001-06-27
HUP9900511A2 (hu) 1999-07-28
CA2222311A1 (fr) 1997-05-01
JP3636473B2 (ja) 2005-04-06
PL186366B1 (pl) 2003-12-31
JP2000503628A (ja) 2000-03-28
DE69603681D1 (de) 1999-09-16
EP0769293A3 (de) 1997-05-02

Similar Documents

Publication Publication Date Title
DE69603681T2 (de) Verwendung mindestens eines beta-adrenergen Agonisten als Antagonist der Substanz P
NO960081L (no) Östrogen-agonist/antagonister
NO964871D0 (no) Nye agonistforbindelser
DE69622652T2 (de) Substituierte indolymethylen-oxindol-analoge als tyrosin kinase inhibitoren
EA199700280A1 (ru) Ингибиторы протеинкиназы с
DE69520032D1 (de) Topische Zusammensetzung enthaltend ein Antagonist der Substanz P
BR9206237A (pt) Uso de derivados de tetrahidrocarbazole como receptores agonistas 5-HT1.
EE04141B1 (et) 5-HT tagasihaarde inhibiitori kombinatsioon h5-HT1B antagonisti või osalise agonistiga
NO974605L (no) Nye heterosykliske forbindelser
ATE160934T1 (de) Verwendung eines antagonisten der substanz p in einer topischen zusammensetzung als antitranspirationsmittel
BR9505382A (pt) Utilização de ao menos um antagonista de substáncia P
BR9709030A (pt) Compensação de nível de liquido para um cilindro emissor
ATE221520T1 (de) Tetrahydrochinoline als nmda antagonisten
DE69431201T2 (de) Verwendung von indolderivaten als 5ht1-agonisten
DE69603239T2 (de) Verwendung von mindestens eines Thermalwassers aus Vichy als Antagonist der Substanz P
EA200200435A1 (ru) Анализ лептина
DE69707098T2 (de) Substituierte tetralylmethylenoxindol-analoga als tyrosinkinase-inhibitoren
EA200000092A1 (ru) Противоаллергические средства
BR9505392A (pt) Utilizações de ao menos um antagonista de substância P
NO981216L (no) Nye heterosykliske forbindelser
ITBO930481A0 (it) "sonda di tastaggio"
FI941611A (fi) Menetelmä aineen vaikutusten arvioimiseksi in vitro
EA199800204A1 (ru) Антагонисты 5-нтрецепторов для лечения дискинезии
KR970012733U (ko) 연료잔량 감지장치
IT1278463B1 (it) Sonda di livello perfezionata.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee